Tandem Therapeutics is built on Mamta’s original discovery, while working in the laboratory of Professor Viola Vogel in the Department of Health Sciences and Technology (HEST), Swiss Federal Institute of Technology, Zürich (ETHZ).

Prior to founding TANDEM Therapeutics, she worked at Hoffmann-La Roche R&D advancing 3D tissue engineering for preclinical cardiac safety. She also has a successful track record in commercial product management in Pharma and MedTech industry. Mamta has a Bachelor’s in Pharmacy and Master’s in Molecular Bioengineering from Technical University Dresden, Germany. She obtained her PhD at ETH Zürich, Switzerland and has advance certification in Pharmaceutical Market Access and Entrepreneurial Leadership in Technology Ventures.

Viola Vogel is a Professor of the Department of Health Science and Technology at the ETH Zürich, Switzerland. She is heading the Laboratory of Applied Mechanobiology. She is core faculty member of the Wyss Translational Center Zurich and an Einstein Visiting Fellow at Berlin Institute of Health, Charité since 2017.

She has made pioneering contributions in applied mechanobiology by deciphering nanoscale mechanisms revealing how mechanical forces switch molecular and cellular functions and translating them into biomedical applications. She is Elected Member of the Leopoldina, the Berlin-​Brandenburg Academy of Sciences, the National Academy of Engineering, the National Academy of Science, USA and also serves on Board of several research organizations.

Martin Behe received his PhD in inorganic chemistry at the University of Basel. He worked at the University Hospitals in Göttingen, Marburg and Freiburg in Germany where he established a group for peptide-based radiopharmaceuticals and its production. 

Since 2011, Martin Behe leads the Pharmacology group at Paul Scherrer Institut and has been associated with Matrix Targeting peptides. He has an extensive background in peptide chemistry, peptide labelling and conjugation as well and critically contributed to development of radio-labelled compounds that are used in the clinic.